ZA975311B - Method of enhancing cognition - Google Patents
Method of enhancing cognitionInfo
- Publication number
- ZA975311B ZA975311B ZA975311A ZA975311A ZA975311B ZA 975311 B ZA975311 B ZA 975311B ZA 975311 A ZA975311 A ZA 975311A ZA 975311 A ZA975311 A ZA 975311A ZA 975311 B ZA975311 B ZA 975311B
- Authority
- ZA
- South Africa
- Prior art keywords
- enhancing cognition
- darifenacin
- treatment
- pharmaceutically acceptable
- cognitive impairment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01007—Acetylcholinesterase (3.1.1.7)
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Control Of Eletrric Generators (AREA)
- Soil Working Implements (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9612710.5A GB9612710D0 (en) | 1996-06-18 | 1996-06-18 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA975311B true ZA975311B (en) | 1998-12-17 |
Family
ID=10795468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA975311A ZA975311B (en) | 1996-06-18 | 1997-06-17 | Method of enhancing cognition |
Country Status (15)
Country | Link |
---|---|
US (1) | US5837724A (pt) |
EP (1) | EP0813870B1 (pt) |
JP (1) | JP3453493B2 (pt) |
KR (1) | KR980000445A (pt) |
AT (1) | ATE243514T1 (pt) |
AU (1) | AU2495697A (pt) |
CA (1) | CA2208111C (pt) |
DE (1) | DE69722999T2 (pt) |
DK (1) | DK0813870T3 (pt) |
ES (1) | ES2197972T3 (pt) |
GB (1) | GB9612710D0 (pt) |
HU (1) | HUP9701060A3 (pt) |
IL (1) | IL121036A0 (pt) |
PT (1) | PT813870E (pt) |
ZA (1) | ZA975311B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19707655A1 (de) * | 1997-02-26 | 1998-08-27 | Hoechst Ag | Kombinationspräparat zur Anwendung bei Demenz |
US20040209849A1 (en) * | 1998-11-27 | 2004-10-21 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of effectors of the central cholinergic nervous system for treatment of delirium |
GB0207104D0 (en) * | 2002-03-26 | 2002-05-08 | Pfizer Ltd | Stable hydrate of a muscarinic receptor antagonist |
EP1615881A2 (en) * | 2003-04-01 | 2006-01-18 | Theravance, Inc. | Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
AU2009229372C1 (en) | 2008-03-27 | 2017-02-02 | Chase Pharmaceuticals Corporation | Use and composition for treating dementia |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
EP2456868A4 (en) | 2009-07-22 | 2013-11-06 | Puretech Ventures | METHOD AND COMPOSITIONS FOR TREATING SUFFERING OF SUFFERING THROUGH MUSCARIN RECEPTOR ACTIVATION |
JP7079777B2 (ja) * | 2017-06-01 | 2022-06-02 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾロキノリン誘導体とドネペジルの併用による認知症治療剤 |
CA3114623C (en) | 2018-09-28 | 2023-01-10 | Karuna Therapeutics, Inc. | Composition comprising xanomeline and trospium for treating disorders ameliorated by muscarinic receptor activation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
GB9400600D0 (en) * | 1994-01-14 | 1994-03-09 | Pfizer Ltd | Treatment of motion seckness |
-
1996
- 1996-06-18 GB GBGB9612710.5A patent/GB9612710D0/en active Pending
-
1997
- 1997-06-05 DE DE69722999T patent/DE69722999T2/de not_active Expired - Lifetime
- 1997-06-05 ES ES97303879T patent/ES2197972T3/es not_active Expired - Lifetime
- 1997-06-05 EP EP97303879A patent/EP0813870B1/en not_active Expired - Lifetime
- 1997-06-05 PT PT97303879T patent/PT813870E/pt unknown
- 1997-06-05 AT AT97303879T patent/ATE243514T1/de active
- 1997-06-05 DK DK97303879T patent/DK0813870T3/da active
- 1997-06-09 IL IL12103697A patent/IL121036A0/xx unknown
- 1997-06-10 JP JP15189997A patent/JP3453493B2/ja not_active Expired - Lifetime
- 1997-06-11 US US08/872,891 patent/US5837724A/en not_active Expired - Lifetime
- 1997-06-16 CA CA002208111A patent/CA2208111C/en not_active Expired - Lifetime
- 1997-06-17 AU AU24956/97A patent/AU2495697A/en not_active Abandoned
- 1997-06-17 ZA ZA975311A patent/ZA975311B/xx unknown
- 1997-06-17 KR KR1019970025073A patent/KR980000445A/ko not_active Application Discontinuation
- 1997-06-17 HU HU9701060A patent/HUP9701060A3/hu unknown
Also Published As
Publication number | Publication date |
---|---|
CA2208111A1 (en) | 1997-12-18 |
DE69722999D1 (de) | 2003-07-31 |
US5837724A (en) | 1998-11-17 |
ES2197972T3 (es) | 2004-01-16 |
CA2208111C (en) | 2002-10-15 |
PT813870E (pt) | 2003-10-31 |
HUP9701060A3 (en) | 1999-03-29 |
AU2495697A (en) | 1998-01-08 |
ATE243514T1 (de) | 2003-07-15 |
GB9612710D0 (en) | 1996-08-21 |
DE69722999T2 (de) | 2003-12-18 |
JPH1059848A (ja) | 1998-03-03 |
EP0813870B1 (en) | 2003-06-25 |
KR980000445A (ko) | 1998-03-30 |
IL121036A0 (en) | 1997-11-20 |
EP0813870A1 (en) | 1997-12-29 |
HU9701060D0 (en) | 1997-08-28 |
JP3453493B2 (ja) | 2003-10-06 |
DK0813870T3 (da) | 2003-08-18 |
HUP9701060A2 (hu) | 1998-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0711902A3 (en) | Fracturing treatment with nitrogen and carbon dioxide in combination | |
ZA976696B (en) | Treated titanium dioxide. | |
HK1046274A1 (en) | Spiro Ä1-azabicycloÄ2.2.2.Üoctane-3,2'(3'h)-furoÄ2,3-bÜpyridine for use in the treatment of psychotic and intellectual impairment disorders. | |
PT936908E (pt) | Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) | |
HK1022270A1 (en) | Use of anti-microtubule agents for treating or preventing multiple-sclerosis | |
EP0725671A4 (en) | METHOD WITH AND WITHOUT A MEMBRANE FOR TREATING ACID GAS | |
ZA976222B (en) | N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use. | |
ZA9811507B (en) | Combination effective for the treatment of impotence. | |
PH31324A (en) | Method of inhibiting imperfect tissue repair. | |
EP0672699A3 (en) | Copolymers of 1,4-dioxepan-2-one and 1,5,8,12-tetraoxacyclotetracan-7-14-diode. | |
IL128379A0 (en) | Treatment of the common cold or allergic rhinitis | |
ZA979731B (en) | Treatment of asthma. | |
ZA97986B (en) | Treatment of liquors. | |
ZA975311B (en) | Method of enhancing cognition | |
AU1556497A (en) | Agents for the treatment and prevention of aids | |
CA2347863A1 (en) | Treatment of disorders of the outer retina | |
GR950100091A (en) | Method for the treatment of plants. | |
ZA935154B (en) | Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions | |
ZA973843B (en) | Treatment of asthma with TNFR-lg. | |
EP0612506A3 (en) | Scalpel to make controlled depth and width incisions. | |
EP0888780A4 (en) | COMPOSITION FOR TREATING CONTACT LENSES AND METHOD FOR USE THEREOF | |
UA29461C2 (uk) | Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу | |
ZA975637B (en) | Method for the treatment of emesis. | |
HUP0102995A3 (en) | Agents and method for the protective treatment of wood | |
AU4402497A (en) | Methods and means for the treatment of malignancies |